Prospective serosurveillance of severe acute respiratory syndrome coronavirus 2 in 1,069 healthcare workers in London, UK, demonstrated that nucleocapsid antibody titers were stable and sustained for < 12 weeks in 312 seropositive participants. This finding was consistent across demographic and clinical variables and contrasts with reports of short-term antibody waning.
All Keywords
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, antibodies, SARS-CoV-2, Healthcare workers, serology, Epidemiology, Health personnel, London, 【초록키워드】 coronavirus, severe acute respiratory syndrome Coronavirus, healthcare worker, nucleocapsid, Prospective, Antibody titer, respiratory, London, Antibody titers, antibody waning, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, demographic and clinical variables, seropositive participants, demonstrated, sustained, clinical variable, 【제목키워드】 response,
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, antibodies, SARS-CoV-2, Healthcare workers, serology, Epidemiology, Health personnel, London, 【초록키워드】 coronavirus, severe acute respiratory syndrome Coronavirus, healthcare worker, nucleocapsid, Prospective, Antibody titer, respiratory, London, Antibody titers, antibody waning, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, demographic and clinical variables, seropositive participants, demonstrated, sustained, clinical variable, 【제목키워드】 response,
영국 런던의 의료 종사자 1,069명을 대상으로 한 중증 급성 호흡기 증후군 코로나바이러스 2의 전향적 혈청 감시는 312명의 혈청 양성 참가자에서 뉴클레오캡시드 항체 역가가 12주 미만 동안 안정적이고 지속됨을 보여주었습니다. 이 발견은 인구 통계학적 및 임상적 변수에 걸쳐 일관되었고 단기 항체 약화에 대한 보고와 대조되었습니다.